Abstract
Thrombolysis has become established as an acute treatment for human stroke. But despite multiple clinical trials, neuroprotective strategies have yet to be proved effective in humans. Here we discuss intrinsic tissue mechanisms of ischaemic brain injury, and present a perspective that broadening of therapeutic targeting beyond excitotoxicity and neuronal calcium overload will be desirable for developing the most effective neuroprotective therapies.
Original language | English |
---|---|
Pages (from-to) | A7-A14 |
Journal | Nature |
Volume | 399 |
Issue number | SUPPL. |
DOIs | |
State | Published - Jun 24 1999 |